Business Daily Media

The Times

.

NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3

  • Written by: ACN Newswire

NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3

- Trial achieved its primary endpoint of pathological Complete Response Rate- Trial achieved its secondary endpoint in operability (R0 rate)- NBTXR3 demonstrated significant superiority and clinical benefits for patients versus standard of care- Safety profile confirmed- Randomized trial validated the first-in-class mode of action of NBTXR3Paris,...

Australian businesses lean into global strategic partnerships (GCCs) for next wave of outsourcing

The Australian corporate landscape is undergoing a fundamental transformation in how it sources talent and innovation. While businesses have traditi...

The New Pressure Gap Crushing Small Businesses

Starting any business and making it prosper is a major undertaking. Part of the challenge is managing the uncertainty, but the financial pressures o...

Click Frenzy returns with a free EOFY sale event for retailers this month

New owners Gabby and Hezi Leibovich bring back Australia’s leading ecommerce sales event with Australia Post as Major Sponsor   Click Frenzy is ...

The 95 Per Cent Failure Rate Is Not An AI Problem

Most Australian SMEs I speak with are already having a go at AI. Some are running formal pilots, others have a team member quietly experimenting o...

New AR tech helping to solve field service skills crisis

AI-enabled augmented reality (AR) smart glasses are emerging as a new practical solution to fill a shortage of field service technicians maintaini...

For Midsize Companies, Global Payroll Systems Matter More to Business-Security Than You Think

When a midsize company expands across borders, its payroll operation becomes exponentially more complex. These organisations typically face a new ...